Testing will allow for identification of convalescent plasma donors, whose plasma can be used in the potential treatment of COVID-19 patients.
The Community Blood Center (CBC) continues to contribute to the fight against the novel coronavirus by making convalescent plasma available for transfusion to patients suffering from severe cases of COVID-19. Today, CBC announces it has the capability to test for the antibody in plasma to identify individuals who can become convalescent plasma donors.
There are two ways to qualify as a convalescent plasma donor. The first is through a positive molecular test at point of diagnosis of infection. The second is laboratory evidence of antibody formation. CBC announces today it now has the capability to conduct this test and will do so with a segment of the blood donor population who may be eligible to become convalescent plasma donors.
The objective of CBC is to supply hospitals with blood and blood components. Therefore, the testing capabilities are reserved strictly to identify potential convalescent plasma donors, should the antibody test be positive. CBC is not capable of testing the general population. CBC is currently setting up the testing and anticipates it will begin to test the first week of June.
Prospective convalescent plasma donors need to meet the following eligibility:
- Had positive medical test diagnosing COVID-19 OR had symptoms of COVID-19 but did not receive a formal medical test diagnosis
- No longer has symptoms of COVID-19
- Meets all blood donor eligibility criteria
Those interested in learning more about convalescent plasma donation should contact CBC at (800) 280-4102 or complete the online form at www.communityblood.org/donate-convalescent-plasma.
Blood and blood components, such as convalescent plasma, remain safe. The antibody testing is not done as a safety measure on the blood itself, but to identify the plasma that could help COVID-19 patients. There is no known risk of transfusion transmission of this virus.
CBC provides blood, platelets and plasma, including convalescent plasma, to hospitals to meet transfusion needs of patients. Among those hospitals CBC supports nearly 30 local hospitals and hospital systems, including ThedaCare. All blood and blood components the ThedaCare system relies on comes exclusively from CBC.
- Dr. Todd Straus, Chief Medical Officer, The Community Blood Center
- Dr. Jennifer Frank, Chief Medical Officer, ThedaCare
Amid the coronavirus pandemic, patients in local hospitals still rely on transfusions for ongoing medical treatments. Blood is still needed for cancer patients, necessary surgeries and emergencies. Healthy and eligible individuals, including first-time donors, are encouraged to schedule an appointment at www.communityblood.org or by calling (800) 280-4102.